|
Mechanismα-synuclein inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismGABAA receptor modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with IOCB Tech sro
0 Patents (Medical) associated with IOCB Tech sro
100 Deals associated with IOCB Tech sro
100 Translational Medicine associated with IOCB Tech sro